Friday 6 November 2026 Export ALNY’s income statement to Excel — free account

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 65.2% from fiscal 2024.

Revenue: +16.7%
EPS: +747.6%
Free cash flow: −4.76%
Total debt: −2.66%

Quarter to September 2026, against a year earlier

156.58 0.08 −0.05%

Follow ALNY

Alert me

Market cap: $21.0B
P/E: 7.9×
Fwd P/E: 13.5×
Dividend yield: —
F-score: 6/9
Altman Z: 7.30
Beneish M: −1.95
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	7	7	5
ROE Full definition →		73.28%	90.36%	96.55%	138.07%
ROA Full definition →		6.82%	11.52%	15.30%	41.25%
ROIC Full definition →		0.00%	0.00%	0.00%	59.37%
Return on Tangible Assets Full definition →		10.13%	15.88%	21.16%	72.30%
Average Days of Receivables Full definition →		76.42	75.26	69.35	78.99
Free Cash Flow per Share Full definition →		3.52	4.84	6.14	6.02
Free Cash Flow Full definition →		465.38	643.34	819.87	806.31
Capital Expenditures Full definition →		(58.70)	(71.56)	(91.95)	(149.64)
Other line items
Cash ROIC Full definition →		9.89%	12.63%	14.45%	9.83%
Accounts Receivable Turnover Full definition →		6.28	6.59	6.49	4.89
Accounts Payable Turnover Full definition →		6.68	7.34	9.29	9.00
Inventory Turnover Full definition →		8.46	10.99	11.58	12.57
Average Days of Payables Full definition →		61.94	56.23	40.34	43.39
Days of Inventory on Hand Full definition →		44.28	37.31	36.26	33.94
Tax Rate Full definition →		(0.03)	(0.02)	0.01	2.39
Research and Development Expense of Revenue Full definition →		35.54%	33.11%	31.41%	31.09%
Selling, General and Administrative Expense of Revenue Full definition →		32.60%	30.17%	27.43%	26.69%
Share Based Compensation of Revenue Full definition →		9.38%	8.44%	7.01%	6.13%
Interest Coverage Full definition →		1.99	2.85	3.52	3.25
Operating CF/Net income Full definition →		1.67	1.33	1.18	0.36
Depreciation/Fixed assets Full definition →		0.11	0.11	0.10	0.09
Capex/Depreciation Full definition →		(1.05)	(1.31)	(1.68)	(2.70)
Revenue per Share Full definition →		28.09	32.26	35.96	37.46
Operating CF per Share Full definition →		3.96	5.38	6.82	7.14
Capex per Share Full definition →		(0.44)	(0.54)	(0.69)	(1.12)
Capex to Sales Full definition →		0.02	0.02	0.02	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly